Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04517266
What this trial is testing

Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer

Who this might be right for
Breast Cancer
Ruijin Hospital 214
Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Testing effectiveness (Phase 2)Active Not RecruitingNCT06394661
What this trial is testing

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 109
Early research (Phase 1)Study completedNCT01046929
What this trial is testing

Limonene Study in Women With Breast Cancer

Who this might be right for
Breast Cancer
University of Arizona 59
Not applicableLooking for participantsNCT07354165
What this trial is testing

Financial Toxicity in Patients With Early-stage Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples 864
Testing effectiveness (Phase 2)Study completedNCT05150652
What this trial is testing

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerNode-negative Breast Cancer+1 more
Irada Ibrahim-zada 8
Testing effectiveness (Phase 2)Looking for participantsNCT06508216
What this trial is testing

Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 50
Not applicableUnknownNCT05264649
What this trial is testing

Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

Who this might be right for
Arthralgia
Show Chwan Memorial Hospital 72
Not applicableStudy completedNCT02010021
What this trial is testing

Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 17
Large-scale testing (Phase 3)Study completedNCT01101438
What this trial is testing

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 3,649
Post-approval studies (Phase 4)UnknownNCT02982148
What this trial is testing

Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients

Who this might be right for
Breast Cancer FemaleEarly-Stage Breast CancerSentinel Lymph Node
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 352
Not applicableUnknownNCT04607473
What this trial is testing

ABUS for Early-stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Samsung Medical Center 675
Large-scale testing (Phase 3)Study completedNCT03433313
What this trial is testing

Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
EirGenix, Inc. 807
Large-scale testing (Phase 3)Study completedNCT00002582
What this trial is testing

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 6,000
Post-approval studies (Phase 4)UnknownNCT00030758
What this trial is testing

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Anglo Celtic Cooperative Oncology Group 816
Not applicableLooking for participantsNCT06035016
What this trial is testing

Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer

Who this might be right for
HER2-positive Breast CancerEarly-stage Breast Cancer
Peking Union Medical College Hospital 300
Large-scale testing (Phase 3)Study completedNCT00878709
What this trial is testing

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 2,840
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06404736
What this trial is testing

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

Who this might be right for
Early Breast CancerNeoadjuvant TherapyTNBC, Triple Negative Breast Cancer
Fudan University 73
Not applicableLooking for participantsNCT06536881
What this trial is testing

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

Who this might be right for
Breast CancerEarly-stage Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Next Page